APP and Alzheimer disease: We applied the APP/PS1 mouse model to explore the impact of intestinal dominant microbiota in improving Aβ plaques in the brain hippocampus and inflammatory factors in the brain and circulating blood to provide new ideas and lay the foundation for the clinical treatment of AD.